Prednisone Recruiting Phase 2 Trials for Castrate Sensitive Prostate Cancer Screening

IndicationsStatusPurposePhase
RecruitingScreening2
clinicaltrials.gov IdentifierTitleDrugs
NCT03860987Neoadjuvant Androgen Deprivation Therapy Combined With Enzalutamide and Abiraterone Using Multiparametric MRI and 18FDCFPyL PET/CT in Newly Diagnosed Prostate Cancer